Anthropic Brings Claude Cowork to Mobile and Web, Expands Into Drug Development

Anthropic is rolling out Claude Cowork, its AI agent for office-style work, to web and mobile for the first time . The desktop app launched in January 2026; starting this week, Max subscribers can start a task from their computer, get status updates on their phone, and return to a finished result even after closing their laptop, using cloud-based background processing that keeps tasks running while devices are offline. Anthropic paired the launch with extended, doubled usage limits for Cowork through August 5.

Anthropic has disclosed that more than 90% of Cowork usage is not software development, with the single largest category, business process work such as reconciling spreadsheets and building reports from call transcripts, accounting for about a third of tasks. The push into everyday office work follows a separate expansion into life sciences: in late June, Anthropic launched Claude Science, a platform bundling more than 60 tools for genomics, proteomics, and structural biology, alongside a new internal drug discovery effort aimed at diseases that traditional biopharma companies tend to skip. That build-out has included acquiring biotech startup Coefficient Bio, adding Novartis CEO Vas Narasimhan to its board, and recruiting AlphaFold co-creator John Jumper from Google DeepMind.

The expansion comes as Anthropic and OpenAI escalate a pricing fight for enterprise customers. Anthropic's annualized revenue has grown from roughly $1 billion in early 2025 to about $47 billion by May 2026, and the company now holds a larger share of enterprise AI spend than OpenAI, prompting reports that OpenAI is weighing its own steep price cuts. Anthropic has also pulled talent from rivals, including MSFT infrastructure veteran Eric Boyd and researchers from Google DeepMind and OpenAI. Worth watching is whether wider Cowork distribution, the life-sciences push, and enterprise price competition together widen Anthropic's lead, and how rivals respond on pricing and product scope.

Related Stocks

• GOOGL
• MSFT